Antibacterial Drug Resistance Market Report

Global and Region Antibacterial Drug Resistance Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：202
  • REPORT CODE：GMM1009547
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Antibacterial Drug Resistance market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Antibacterial Drug Resistancemarket, defines the market attractiveness level of Antibacterial Drug Resistance market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Antibacterial Drug Resistance industry, describes the types of Antibacterial Drug Resistance market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibacterial Drug Resistance market and the development prospects and opportunities of Antibacterial Drug Resistance industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibacterial Drug Resistance market in Chapter 13.

    By Player:

    • Abgentis

    • Osel

    • GSK

    • Absynth Biologics

    • Morphochem

    • PENDOPHARM

    • Demuris

    • InterMune

    • NanoSafe Coatings

    • Arpida

    • Acino Holdings

    • ContraFect

    • Achaogen

    • Novexel

    • Nabriva Therapeutics

    • Pfizer

    • Isis Pharmaceuticals

    • ANTABIO

    • AAIPharma Services

    • Assembly Biosciences

    • Microbecide

    • Austell Laboratories

    • Cerexa

    • Aventis Pharma

    • VenatoRx Pharmaceuticals

    • Abbott Laboratories

    • Lyndra

    • Evolva Holding

    By Type:

    • Telavancin (Vibativ)

    • Ceftaroline Fosamil (Teflaro/ Zinforo)

    • Fidaxomicin (Dificid / Dificlir)

    • Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)

    • Dalbavancin (Dalvance/ Xydalba)

    • Tedizolid Phosphate (Sivextro)

    • Oritavancin (Orbactiv/ Nuvocid)

    • Ceftolozane-Tazobactam (Zerbaxa)

    • Ceftazidime-Avibactam (Avycaz/ Zavicefta)

    • PHASE III DRUGS

    By End-User:

    • Gram-Positive

    • Gram-Negative

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Antibacterial Drug Resistance Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Antibacterial Drug Resistance Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Antibacterial Drug Resistance Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Antibacterial Drug Resistance Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Antibacterial Drug Resistance Market Analysis and Outlook to 2022

    • 7.1 Global Antibacterial Drug Resistance Consumption (2017-2022)

    • 7.2 United States Antibacterial Drug Resistance Consumption (2017-2022)

    • 7.3 Europe Antibacterial Drug Resistance Consumption (2017-2022)

    • 7.4 China Antibacterial Drug Resistance Consumption (2017-2022)

    • 7.5 Japan Antibacterial Drug Resistance Consumption (2017-2022)

    • 7.6 India Antibacterial Drug Resistance Consumption (2017-2022)

    • 7.7 South Korea Antibacterial Drug Resistance Consumption (2017-2022)

    8 Region and Country-wise Antibacterial Drug Resistance Market Analysis and Outlook to 2028

    • 8.1 Global Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    • 8.2 United States Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    • 8.3 Europe Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    • 8.4 China Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    • 8.5 Japan Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    • 8.6 India Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    • 8.7 South Korea Antibacterial Drug Resistance Consumption Forecast (2022-2028)

    9 Global Antibacterial Drug Resistance Market Outlook by Types and Applications to 2022

    • 9.1 Global Antibacterial Drug Resistance Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Telavancin (Vibativ) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ceftaroline Fosamil (Teflaro/ Zinforo) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Fidaxomicin (Dificid / Dificlir) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Dalbavancin (Dalvance/ Xydalba) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Tedizolid Phosphate (Sivextro) Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Oritavancin (Orbactiv/ Nuvocid) Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Ceftolozane-Tazobactam (Zerbaxa) Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Ceftazidime-Avibactam (Avycaz/ Zavicefta) Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global PHASE III DRUGS Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antibacterial Drug Resistance Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Gram-Positive Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Gram-Negative Consumption and Growth Rate (2017-2022)

    10 Global Antibacterial Drug Resistance Market Outlook by Types and Applications to 2028

    • 10.1 Global Antibacterial Drug Resistance Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Telavancin (Vibativ) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ceftaroline Fosamil (Teflaro/ Zinforo) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Fidaxomicin (Dificid / Dificlir) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Dalbavancin (Dalvance/ Xydalba) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Tedizolid Phosphate (Sivextro) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Oritavancin (Orbactiv/ Nuvocid) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Ceftolozane-Tazobactam (Zerbaxa) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Ceftazidime-Avibactam (Avycaz/ Zavicefta) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global PHASE III DRUGS Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Antibacterial Drug Resistance Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Gram-Positive Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Gram-Negative Consumption Forecast and Growth Rate (2022-2028)

    11 Global Antibacterial Drug Resistance Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Antibacterial Drug Resistance Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Antibacterial Drug Resistance Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Antibacterial Drug Resistance Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Antibacterial Drug Resistance Market Competitive Analysis

    • 14.1 Abgentis

      • 14.1.1 Abgentis Company Details

      • 14.1.2 Abgentis Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Abgentis Antibacterial Drug Resistance Product and Service

    • 14.2 Osel

      • 14.2.1 Osel Company Details

      • 14.2.2 Osel Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Osel Antibacterial Drug Resistance Product and Service

    • 14.3 GSK

      • 14.3.1 GSK Company Details

      • 14.3.2 GSK Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GSK Antibacterial Drug Resistance Product and Service

    • 14.4 Absynth Biologics

      • 14.4.1 Absynth Biologics Company Details

      • 14.4.2 Absynth Biologics Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Absynth Biologics Antibacterial Drug Resistance Product and Service

    • 14.5 Morphochem

      • 14.5.1 Morphochem Company Details

      • 14.5.2 Morphochem Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Morphochem Antibacterial Drug Resistance Product and Service

    • 14.6 PENDOPHARM

      • 14.6.1 PENDOPHARM Company Details

      • 14.6.2 PENDOPHARM Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 PENDOPHARM Antibacterial Drug Resistance Product and Service

    • 14.7 Demuris

      • 14.7.1 Demuris Company Details

      • 14.7.2 Demuris Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Demuris Antibacterial Drug Resistance Product and Service

    • 14.8 InterMune

      • 14.8.1 InterMune Company Details

      • 14.8.2 InterMune Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 InterMune Antibacterial Drug Resistance Product and Service

    • 14.9 NanoSafe Coatings

      • 14.9.1 NanoSafe Coatings Company Details

      • 14.9.2 NanoSafe Coatings Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 NanoSafe Coatings Antibacterial Drug Resistance Product and Service

    • 14.10 Arpida

      • 14.10.1 Arpida Company Details

      • 14.10.2 Arpida Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Arpida Antibacterial Drug Resistance Product and Service

    • 14.11 Acino Holdings

      • 14.11.1 Acino Holdings Company Details

      • 14.11.2 Acino Holdings Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Acino Holdings Antibacterial Drug Resistance Product and Service

    • 14.12 ContraFect

      • 14.12.1 ContraFect Company Details

      • 14.12.2 ContraFect Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 ContraFect Antibacterial Drug Resistance Product and Service

    • 14.13 Achaogen

      • 14.13.1 Achaogen Company Details

      • 14.13.2 Achaogen Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Achaogen Antibacterial Drug Resistance Product and Service

    • 14.14 Novexel

      • 14.14.1 Novexel Company Details

      • 14.14.2 Novexel Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Novexel Antibacterial Drug Resistance Product and Service

    • 14.15 Nabriva Therapeutics

      • 14.15.1 Nabriva Therapeutics Company Details

      • 14.15.2 Nabriva Therapeutics Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Nabriva Therapeutics Antibacterial Drug Resistance Product and Service

    • 14.16 Pfizer

      • 14.16.1 Pfizer Company Details

      • 14.16.2 Pfizer Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Pfizer Antibacterial Drug Resistance Product and Service

    • 14.17 Isis Pharmaceuticals

      • 14.17.1 Isis Pharmaceuticals Company Details

      • 14.17.2 Isis Pharmaceuticals Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Isis Pharmaceuticals Antibacterial Drug Resistance Product and Service

    • 14.18 ANTABIO

      • 14.18.1 ANTABIO Company Details

      • 14.18.2 ANTABIO Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 ANTABIO Antibacterial Drug Resistance Product and Service

    • 14.19 AAIPharma Services

      • 14.19.1 AAIPharma Services Company Details

      • 14.19.2 AAIPharma Services Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 AAIPharma Services Antibacterial Drug Resistance Product and Service

    • 14.20 Assembly Biosciences

      • 14.20.1 Assembly Biosciences Company Details

      • 14.20.2 Assembly Biosciences Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Assembly Biosciences Antibacterial Drug Resistance Product and Service

    • 14.21 Microbecide

      • 14.21.1 Microbecide Company Details

      • 14.21.2 Microbecide Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Microbecide Antibacterial Drug Resistance Product and Service

    • 14.22 Austell Laboratories

      • 14.22.1 Austell Laboratories Company Details

      • 14.22.2 Austell Laboratories Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Austell Laboratories Antibacterial Drug Resistance Product and Service

    • 14.23 Cerexa

      • 14.23.1 Cerexa Company Details

      • 14.23.2 Cerexa Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Cerexa Antibacterial Drug Resistance Product and Service

    • 14.24 Aventis Pharma

      • 14.24.1 Aventis Pharma Company Details

      • 14.24.2 Aventis Pharma Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Aventis Pharma Antibacterial Drug Resistance Product and Service

    • 14.25 VenatoRx Pharmaceuticals

      • 14.25.1 VenatoRx Pharmaceuticals Company Details

      • 14.25.2 VenatoRx Pharmaceuticals Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 VenatoRx Pharmaceuticals Antibacterial Drug Resistance Product and Service

    • 14.26 Abbott Laboratories

      • 14.26.1 Abbott Laboratories Company Details

      • 14.26.2 Abbott Laboratories Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Abbott Laboratories Antibacterial Drug Resistance Product and Service

    • 14.27 Lyndra

      • 14.27.1 Lyndra Company Details

      • 14.27.2 Lyndra Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Lyndra Antibacterial Drug Resistance Product and Service

    • 14.28 Evolva Holding

      • 14.28.1 Evolva Holding Company Details

      • 14.28.2 Evolva Holding Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 Evolva Holding Antibacterial Drug Resistance Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Antibacterial Drug Resistance

    • Figure Antibacterial Drug Resistance Picture

    • Table Global Antibacterial Drug Resistance Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibacterial Drug Resistance Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibacterial Drug Resistance Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Antibacterial Drug Resistance Consumption by Country (2017-2022)

    • Figure United States Antibacterial Drug Resistance Consumption and Growth Rate (2017-2022)

    • Table Europe Antibacterial Drug Resistance Consumption and Growth Rate (2017-2022)

    • Figure China Antibacterial Drug Resistance Consumption and Growth Rate (2017-2022)

    • Figure Japan Antibacterial Drug Resistance Consumption and Growth Rate (2017-2022)

    • Figure India Antibacterial Drug Resistance Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antibacterial Drug Resistance Consumption and Growth Rate (2017-2022)

    • Figure Global Antibacterial Drug Resistance Consumption Forecast by Country (2022-2028)

    • Figure United States Antibacterial Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antibacterial Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Antibacterial Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antibacterial Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antibacterial Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antibacterial Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Telavancin (Vibativ) Consumption and Growth Rate (2017-2022)

    • Figure Global Ceftaroline Fosamil (Teflaro/ Zinforo) Consumption and Growth Rate (2017-2022)

    • Figure Global Fidaxomicin (Dificid / Dificlir) Consumption and Growth Rate (2017-2022)

    • Figure Global Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Consumption and Growth Rate (2017-2022)

    • Figure Global Dalbavancin (Dalvance/ Xydalba) Consumption and Growth Rate (2017-2022)

    • Figure Global Tedizolid Phosphate (Sivextro) Consumption and Growth Rate (2017-2022)

    • Figure Global Oritavancin (Orbactiv/ Nuvocid) Consumption and Growth Rate (2017-2022)

    • Figure Global Ceftolozane-Tazobactam (Zerbaxa) Consumption and Growth Rate (2017-2022)

    • Figure Global Ceftazidime-Avibactam (Avycaz/ Zavicefta) Consumption and Growth Rate (2017-2022)

    • Figure Global PHASE III DRUGS Consumption and Growth Rate (2017-2022)

    • Figure Global Gram-Positive Consumption and Growth Rate (2017-2022)

    • Figure Global Gram-Negative Consumption and Growth Rate (2017-2022)

    • Figure Global Telavancin (Vibativ) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ceftaroline Fosamil (Teflaro/ Zinforo) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fidaxomicin (Dificid / Dificlir) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dalbavancin (Dalvance/ Xydalba) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tedizolid Phosphate (Sivextro) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oritavancin (Orbactiv/ Nuvocid) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ceftolozane-Tazobactam (Zerbaxa) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ceftazidime-Avibactam (Avycaz/ Zavicefta) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PHASE III DRUGS Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gram-Positive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gram-Negative Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Antibacterial Drug Resistance Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Antibacterial Drug Resistance Export by Region (Top 5 Countries) (2017-2028)

    • Table Abgentis (Foundation Year, Company Profile and etc.)

    • Table Abgentis Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abgentis Antibacterial Drug Resistance Product and Service

    • Table Osel (Foundation Year, Company Profile and etc.)

    • Table Osel Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Osel Antibacterial Drug Resistance Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Antibacterial Drug Resistance Product and Service

    • Table Absynth Biologics (Foundation Year, Company Profile and etc.)

    • Table Absynth Biologics Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Absynth Biologics Antibacterial Drug Resistance Product and Service

    • Table Morphochem (Foundation Year, Company Profile and etc.)

    • Table Morphochem Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Morphochem Antibacterial Drug Resistance Product and Service

    • Table PENDOPHARM (Foundation Year, Company Profile and etc.)

    • Table PENDOPHARM Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table PENDOPHARM Antibacterial Drug Resistance Product and Service

    • Table Demuris (Foundation Year, Company Profile and etc.)

    • Table Demuris Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Demuris Antibacterial Drug Resistance Product and Service

    • Table InterMune (Foundation Year, Company Profile and etc.)

    • Table InterMune Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table InterMune Antibacterial Drug Resistance Product and Service

    • Table NanoSafe Coatings (Foundation Year, Company Profile and etc.)

    • Table NanoSafe Coatings Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanoSafe Coatings Antibacterial Drug Resistance Product and Service

    • Table Arpida (Foundation Year, Company Profile and etc.)

    • Table Arpida Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arpida Antibacterial Drug Resistance Product and Service

    • Table Acino Holdings (Foundation Year, Company Profile and etc.)

    • Table Acino Holdings Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acino Holdings Antibacterial Drug Resistance Product and Service

    • Table ContraFect (Foundation Year, Company Profile and etc.)

    • Table ContraFect Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table ContraFect Antibacterial Drug Resistance Product and Service

    • Table Achaogen (Foundation Year, Company Profile and etc.)

    • Table Achaogen Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Achaogen Antibacterial Drug Resistance Product and Service

    • Table Novexel (Foundation Year, Company Profile and etc.)

    • Table Novexel Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novexel Antibacterial Drug Resistance Product and Service

    • Table Nabriva Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Nabriva Therapeutics Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nabriva Therapeutics Antibacterial Drug Resistance Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Antibacterial Drug Resistance Product and Service

    • Table Isis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Isis Pharmaceuticals Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Isis Pharmaceuticals Antibacterial Drug Resistance Product and Service

    • Table ANTABIO (Foundation Year, Company Profile and etc.)

    • Table ANTABIO Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table ANTABIO Antibacterial Drug Resistance Product and Service

    • Table AAIPharma Services (Foundation Year, Company Profile and etc.)

    • Table AAIPharma Services Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table AAIPharma Services Antibacterial Drug Resistance Product and Service

    • Table Assembly Biosciences (Foundation Year, Company Profile and etc.)

    • Table Assembly Biosciences Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Assembly Biosciences Antibacterial Drug Resistance Product and Service

    • Table Microbecide (Foundation Year, Company Profile and etc.)

    • Table Microbecide Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Microbecide Antibacterial Drug Resistance Product and Service

    • Table Austell Laboratories (Foundation Year, Company Profile and etc.)

    • Table Austell Laboratories Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Austell Laboratories Antibacterial Drug Resistance Product and Service

    • Table Cerexa (Foundation Year, Company Profile and etc.)

    • Table Cerexa Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cerexa Antibacterial Drug Resistance Product and Service

    • Table Aventis Pharma (Foundation Year, Company Profile and etc.)

    • Table Aventis Pharma Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aventis Pharma Antibacterial Drug Resistance Product and Service

    • Table VenatoRx Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table VenatoRx Pharmaceuticals Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table VenatoRx Pharmaceuticals Antibacterial Drug Resistance Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Antibacterial Drug Resistance Product and Service

    • Table Lyndra (Foundation Year, Company Profile and etc.)

    • Table Lyndra Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lyndra Antibacterial Drug Resistance Product and Service

    • Table Evolva Holding (Foundation Year, Company Profile and etc.)

    • Table Evolva Holding Antibacterial Drug Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Evolva Holding Antibacterial Drug Resistance Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US